Reporting of PPI and the MCID in phase III/IV randomised controlled trials—a systematic review

BACKGROUND: Patient and public involvement (PPI) in clinical trial design contributes to ensuring the research objectives and outcome measures are relevant to patients. The minimal clinically important difference (MCID) in the primary outcome influences trial design and feasibility and should be pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Brennan, Joseph, Poon, Michael T. C., Christopher, Edward, Fulton, Olivia, Porteous, Carol, Brennan, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233858/
https://www.ncbi.nlm.nih.gov/pubmed/37259102
http://dx.doi.org/10.1186/s13063-023-07367-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233858/
https://www.ncbi.nlm.nih.gov/pubmed/37259102
http://dx.doi.org/10.1186/s13063-023-07367-0

Ejemplares similares